text: The current most updated guidelines state that for UA/NSTEMI patients presenting to the hospital, aspirin should be administered immediately, and if the patient cannot take aspirin, another<unk>  agent, namely clopidogrel or prasugrel (in PCI treated patients) should be given. UA/NSTEMI patients at moderate to high risk who will be undergoing PCI should be given dual<unk><unk>  consisting of aspirin and one of the following; clopidogrel, ticagrelor, eptifibatide and prasugrel, depending on whether the second agent is given before or during PCI. Addtional situation specific guidelines are given below.
option_0: Unstable angina/NSTEMI Antiplatelet therapy recommendations
option_1: Chronic stable angina treatment anti-lipid agents
option_2: Chronic stable angina treatment aspirin
option_3: Chronic stable angina treatment clopidogrel
option_4: Chronic stable angina treatment lipid management
option_5: Chronic stable angina risk stratification coronary angiography
option_6: Chronic stable angina treatment calcium channel blockers
option_7: Chronic stable angina treatment angiotensin converting enzyme inhibitors 